Inflammatory biomarkers: impact for diabetes and diabetic vascular disease

Q: What is the clinical evidence from this study?

Study design: Review. Population: Type 2 diabetes and diabetic vascular disease.

Q: What does this research mean for the field?

Co-administration of pioglitazone and statins improves intima-media thickness, enhances endothelial function, and reduces inflammatory markers in patients with cardiovascular risk factors. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

Marijan Bosevski; Lily Stojanovska; Vasso Apostolopoulos

doi:10.1093/abbs/gmv109

October 29, 2015Acta Biochimica et Biophysica SinicaOpen Access

Inflammatory biomarkers: impact for diabetes and diabetic vascular disease

View Full Paper

Ask AI

Bookmark

Share

PICO

P

Population

Type 2 diabetes and diabetic vascular disease

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Bosevski et al. (2015) conducted a review in Type 2 diabetes and diabetic vascular disease.

synapsesocial.com/papers/6a70282ba528af2d65c35db6 https://doi.org/10.1093/abbs/gmv109

View Full Paper

Ask AI

Bookmark

Share

Inflammatory biomarkers: impact for diabetes and diabetic vascular disease

PICO

Ask about this paper

Abstract

Discussion

Cite This Study

Inflammatory biomarkers: impact for diabetes and diabetic vascular disease

PICO

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading